Search
Close this search box.
Logo Asphalion

Tumor-LN-oC | Tumor and Lymph Node on Chip for cancer studies

The EU-funded Tumor-LN-oC project proposes the development and validation of a TRL 5 tumor-lymph node-on-chip (Tumor-LN-oC) platform composed of 3D tissue models and microfluidic chips which will connect surgically removed human primary tumors and LN tissue from the same lung cancer patient.

The EU-funded Tumor-LN-oC project proposes the development and validation of a TRL 5 tumor-lymph node-on-chip (Tumor-LN-oC) platform composed of 3D tissue models and microfluidic chips which will connect surgically removed human primary tumors and LN tissue from the same lung cancer patient.
September 10, 2021

✹ Lung cancer is the leading cause of death (1.8 million worldwide, 267K in Europe) and accounts for 1/5 of total cancer deaths. It is believed that up to 70% of metastases occurs through the lymphatic system with lymphatic vessels and lymph nodes (LN) mediating the process, while the rest of them are of hematogenous origin and occur through the blood stream.

✹The EU-funded Tumor-LN-oC project proposes the development and validation of a TRL 5 tumor-lymph node-on-chip (Tumor-LN-oC) platform composed of 3D tissue models and microfluidic chips which will connect surgically removed human primary tumors and LN tissue from the same lung cancer patient. This will serve as a “biological twin” of the patient and will allow to study the interaction of primary tumors with LNs for individual patients.

✹ASPHALION is proud to be partner of this EU granted project, providing Regulatory Support throughout all stages of the project.

✹Also, we are more than happy to share the news with you about the launch of the project´s website:

https://tumor-ln-oc.eu/

✹For a complete overview about the project, we invite you to have a look at the press release:

https://tumor-ln-oc.eu/wp-content/uploads/2021/09/Tumor-LN-oC-press-release.pdf

✹For further information, you can contact us at: horizon@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

SINPAIN Video | Illustrating the Future of Knee Osteoarthritis Treatment

The EU-funded research project SINPAIN aims to improve the quality of life for those affected by knee osteoarthritis (OA). By developing a new generation of advanced, safe, efficient, and cost-effective nanotherapeutics based on small interfering RNA (siRNA), the project aims to alleviate the pain experienced by knee osteoarthritis patients worldwide and reduce the significant costs associated with the disease.

RBDCOV PROJECT | PODCAST SERIES

‘RBDCOV Talks’ brings vaccine clinical research closer to the general audience through a podcast series with 10 scientists, clinicians, specialists and community advocates who are partners in the project.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting